\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ surgery\\ followed\\ by\\ radiation\\ therapy\\.\ \(0\)\
\-\ \\â\\€\\¢\\ 4\\ cm\\ mass\\ in\\ right\\ cerebellar\\ hemisphere\\.\ \(1\)\
\-\ \\â\\€\\¢\\ isointense\\ to\\ slighly\\ hyperintense\\ on\\ t1\ \(0\)\
\-\ \\â\\€\\¢\\ very\\ low\\ signal\\ on\\ t2\\ images\ \(0\)\
\-\ \\â\\€\\¢\\ heterogeneous\\ enhancement\\ following\\ contrast\\.\ \(0\)\
\-\ cerebellar\\ metastatic\\ disease\\ from\\ colon\\ cancer\ \(0\)\
\-\ \\â\\€\\¢\\ cerebellar\\ hematoma\\ secondary\\ to\\ vascular\\ malformation\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ metastatic\\ adenocarcinoma\\ with\\ mucin\\ \\(colon\\ cancer\\)\ \(0\)\
\-\ \\â\\€\\¢\\ primary\\ glioma\\ \\(high\\ grade\\)\ \(0\)\
\-\ 50\\ \\ year\\ old\\ \\ woman\\ with\\ history\\ of\\ colon\\ cancer\\ with\\ known\\ metastatic\\ disease\\ to\\ the\\ liver\\.\\ \\ presents\\ to\\ local\\ doctor\\ with\\ headache\\ and\\ ataxia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cerebellar\\:\\ 0\\.3690191624326888\ \(0\)\
\-\ colon\\:\\ 0\\.343345594448302\ \(0\)\
\-\ cancer\\:\\ 0\\.30035135161312093\ \(0\)\
\-\ metastatic\\:\\ 0\\.24731261975587704\ \(0\)\
\-\ slighly\\:\\ 0\\.24037848272630735\ \(0\)\
\-\ mucin\\:\\ 0\\.18558517756585785\ \(0\)\
\-\ doctor\\:\\ 0\\.16144090773141287\ \(0\)\
\-\ to\\:\\ 0\\.15030886284500103\ \(0\)\
\-\ ataxia\\:\\ 0\\.14595272330608536\ \(0\)\
\-\ hemisphere\\:\\ 0\\.14066504849877393\ \(0\)\
\-\ isointense\\:\\ 0\\.13601101658923714\ \(0\)\
\-\ local\\:\\ 0\\.1293888789219789\ \(0\)\
\-\ glioma\\:\\ 0\\.1276882882526022\ \(0\)\
\-\ disease\\:\\ 0\\.12618963321507154\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.12285363336932688\ \(0\)\
\-\ hyperintense\\:\\ 0\\.11956454438082935\ \(0\)\
\-\ with\\:\\ 0\\.11773034296561714\ \(0\)\
\-\ malformation\\:\\ 0\\.1159286186906786\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.10879106097396885\ \(0\)\
\-\ grade\\:\\ 0\\.10808600192408666\ \(0\)\
\-\ very\\:\\ 0\\.10782639381550907\ \(0\)\
\-\ hematoma\\:\\ 0\\.10520560092367226\ \(0\)\
\-\ 50\\:\\ 0\\.10497275690595641\ \(0\)\
\-\ liver\\:\\ 0\\.10369081551023167\ \(0\)\
\-\ headache\\:\\ 0\\.103617314737675\ \(0\)\
\-\ followed\\:\\ 0\\.10150254317735342\ \(0\)\
\-\ radiation\\:\\ 0\\.09960792242454565\ \(0\)\
\-\ vascular\\:\\ 0\\.09923238148545366\ \(0\)\
\-\ known\\:\\ 0\\.09731517178151855\ \(0\)\
\-\ t1\\:\\ 0\\.09365255005756876\ \(0\)\
\-\ primary\\:\\ 0\\.09242446154534983\ \(0\)\
\-\ on\\:\\ 0\\.09079242655347972\ \(0\)\
\-\ following\\:\\ 0\\.0901717382681792\ \(0\)\
\-\ lymphoma\\:\\ 0\\.08951893832818196\ \(0\)\
\-\ secondary\\:\\ 0\\.08909255346023759\ \(0\)\
\-\ enhancement\\:\\ 0\\.08651584466444681\ \(0\)\
\-\ t2\\:\\ 0\\.08647751737059658\ \(0\)\
\-\ therapy\\:\\ 0\\.08636286885089045\ \(0\)\
\-\ cm\\:\\ 0\\.08632476326236052\ \(0\)\
\-\ low\\:\\ 0\\.08624871700502879\ \(0\)\
\-\ high\\:\\ 0\\.08542638045674848\ \(0\)\
\-\ signal\\:\\ 0\\.0852064903639181\ \(0\)\
\-\ surgery\\:\\ 0\\.0808130370506195\ \(0\)\
\-\ woman\\:\\ 0\\.07828196230121044\ \(0\)\
\-\ contrast\\:\\ 0\\.07303258136762948\ \(0\)\
\-\ presents\\:\\ 0\\.07230688979184569\ \(0\)\
\-\ images\\:\\ 0\\.06952840241568341\ \(0\)\
\-\ by\\:\\ 0\\.06383036221468856\ \(0\)\
\-\ from\\:\\ 0\\.05969677693782839\ \(0\)\
\-\ history\\:\\ 0\\.057427138312664314\ \(0\)\
\-\ mass\\:\\ 0\\.05741442419426261\ \(0\)\
\-\ right\\:\\ 0\\.0498339987439241\ \(0\)\
\-\ year\\:\\ 0\\.04632259616620493\ \(0\)\
\-\ old\\:\\ 0\\.04448572728415257\ \(0\)\
\-\ in\\:\\ 0\\.03739226073334457\ \(0\)\
\-\ and\\:\\ 0\\.031059730324851726\ \(0\)\
\-\ the\\:\\ 0\\.029992300185093385\ \(0\)\
\-\ of\\:\\ 0\\.029415010279771333\ \(0\)\
